Oxford Immunotec Global PLC Ordinary Shares
OXFD
OXFD was delisted on the 5th of March, 2021.
49 hedge funds and large institutions have $178M invested in Oxford Immunotec Global PLC Ordinary Shares in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 17 reducing their positions, and 13 closing their positions.
12% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 17
7% less capital invested
Capital invested by funds: $192M → $178M (-$13.8M)
16% less funds holding
Funds holding: 58 → 49 (-9)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
69% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
+$6.09M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$1.74M |
| 3 |
Axa
Paris,
France
|
+$1.74M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$1.65M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$1.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCC
Dow Chemical Company
Midland,
Michigan
|
-$4.64M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$2.24M |
| 3 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$1.77M |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
-$1.31M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$650K |
OXFD Hedge Fund Activity: Q3 2014 in Review
49 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2014, worth a combined $178M — down 7.2% from $192M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of OXFD and 4 opened new positions — a net loss of 9 holders — while 17 trimmed existing stakes and 19 added.
The largest buyer was Tiverton Asset Management, adding an estimated $6.09M. The largest seller was Dow Chemical Company, exiting entirely with an estimated $4.64M sold.
- 49 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2014, down from 58 in Q2 2014.
- Funds reported $178M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2014, down 7.2% quarter-over-quarter.
- 4 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2014 and 13 closed out, a net change of -9 holders.
- The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2014 was Tiverton Asset Management, an estimated $6.09M added.
- The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2014 was Dow Chemical Company, an estimated $4.64M sold.
Based on aggregated 13F filings for Q3 2014.